Status:

WITHDRAWN

Nasal Fentanyl for Chronic Cancer Pain

Lead Sponsor:

Norwegian University of Science and Technology

Collaborating Sponsors:

St. Olavs Hospital

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Conditions:

Cancer

Pain

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Today, patients with cancer pain in need of opioids for moderate to severe pain get long-acting morphine twice a day and morphine tablets taken on demand in addition. This procedure might be based on ...

Eligibility Criteria

Inclusion

  • Cancer disease
  • Adult (older than 18 years)
  • Cancer-related pain \> 4 on an 11 point Numerical Rating Scale (NRS)
  • In the need of opioids (step II or III)
  • Able to use nasal drugs.
  • Life expectancy of \> 6 months
  • Karnofsky status \> = 60
  • Women of child bearing potential must use adequate contraception
  • Informed consent given according to applicable requirements before any trial-related activities.

Exclusion

  • Use of opioids for moderate and severe pain
  • History of substance abuse.\*
  • Pathological conditions of the nasal cavity as contraindication to nasal fentanyl
  • Renal- or liver- failure, defined as creatinin \> 150 and alanine-amino transferase (ALAT) \> x 1.5 reference value
  • Sleep apnoea syndrome, severe chronic obstructive lung disease or illnesses leading to severe respiratory depression.
  • Psychiatric disease
  • Neurological disease giving dizziness or sedation
  • Cognitive impairment which makes the patient unable to complete questionnaires or not able to comply with the study procedures.
  • Previous or ongoing facial radiotherapy
  • Recurrent nose bleeding
  • Known hypersensitivity to the active substances or excipients of the study drugs
  • Pregnant or breastfeeding women
  • Treated with monoamine oxidase (MAO) inhibitor within the last 14 days

Key Trial Info

Start Date :

January 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2020

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01906073

Start Date

January 1 2017

End Date

December 1 2020

Last Update

December 10 2020

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.